Alglucosidase alfa

阿葡糖苷酶α

Report date: 2022/01/14 13:23:58
First In Class

Base Information

Drug NameAlglucosidase alfa
Drug Alias Name阿糖苷酶αrecombinant human acid alpha-glucosidasehuman acid alpha-glucosidasealglucosidasum alfaalglucosidase alfa +[15] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha glucosidase replacements
TargetsGlycogen
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsGlycogen Storage Disease Type II
Approved Indications in ChinaGlycogen Storage Disease Type II
Original Approved Country/TerritoryEU
Original Approved Date2006/03/28
Country/TerritoryBelgiumUnited StatesTaiwan +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofiGenzyme Europe BvGenzyme Corp
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeA16AB07
Related LinksWikipediaDrugBankKEGG